Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ZEVRA THERAPEUTICS, INC. | Director | Stock Option (right to buy) | 49.2K | May 13, 2024 | Direct | ||
Kintara Therapeutics, Inc. | Director | Options (Right to Buy) | 8.5K | Aug 30, 2023 | Direct | ||
ARTELO BIOSCIENCES, INC. | Director | Stock Option (right to buy) | 1.08K | Feb 28, 2024 | Direct |